Results and analysis:
Participants: Total100 patients took part in this survey. 15
patients filled in paper survey proforma before COVID-19 outbreak and
the remaining 85 responded to the telephonic survey. Mean age of the
participated patients in this survey was 49 years old, ranging from 18
to 77 years. There were 53 males and 46 females and the male: female
ratio was 1.15:1.
When analysing patient’s response, one respondent was using otrovine
instead of steroid spray. Hence, we excluded this patient from the
study, which dropped the total number of participants included in the
study to 99.
Patient responses: Patient responses to the survey questions are
as below:
Who prescribed this nose spray?
- ENT 53% (53 patients).
- GP 42% (42 patients).
- Over the counter 3% (3 patients).
- 1 % (1 patient) cannot remember who prescribed the spray
None of the spray was prescribed by the immunologist.
Were you shown how to use nose spray?
- 40% (40 patients) responded yes
- 60% (59 patients) responded No
Further breakdown of the taught spray technique in those 40% cases was:
- 24% of cases (24 patients) by the ENT team.
- 15% of cases (15 patients) by GP.
- 1% of cases (1 case) by an asthma nurse.